{
            "title": "Current and Future Development in Lung Cancer Diagnosis",
            "outline": [
                {
                    "level": "H1",
                    "text": "1. Introduction",
                    "page": 1
                },
                {
                    "level": "H1",
                    "text": "2. Lung Cancer Staging",
                    "page": 2
                },
                {
                    "level": "H1",
                    "text": "3. Classification",
                    "page": 3
                },
                {
                    "level": "H1",
                    "text": "4. SCLC",
                    "page": 4
                },
                {
                    "level": "H1",
                    "text": "5. NSCLC",
                    "page": 4
                },
                {
                    "level": "H1",
                    "text": "6. Traditional Diagnosis and Screening",
                    "page": 5
                },
                {
                    "level": "H2",
                    "text": "6.1. Screening High-Risk Groups",
                    "page": 5
                },
                {
                    "level": "H2",
                    "text": "6.2. Radiographic Screening and Diagnosis",
                    "page": 5
                },
                {
                    "level": "H2",
                    "text": "6.3. Sputum Examination",
                    "page": 6
                },
                {
                    "level": "H2",
                    "text": "6.4. Bronchoscopy and Lung Tissue Biopsy",
                    "page": 6
                },
                {
                    "level": "H1",
                    "text": "7. Lung Tissue Biopsies",
                    "page": 7
                },
                {
                    "level": "H1",
                    "text": "8. Transition to Biomarker Applications",
                    "page": 8
                },
                {
                    "level": "H2",
                    "text": "8.1. cfDNA",
                    "page": 8
                },
                {
                    "level": "H2",
                    "text": "8.2. Blood Circulating Antigens",
                    "page": 8
                },
                {
                    "level": "H2",
                    "text": "8.3. Cell-Free DNA (cfDNA) and Circulating Tumor Cells (CTCs)",
                    "page": 9
                },
                {
                    "level": "H1",
                    "text": "9. Liquid Biopsies Use in Lung Cancer",
                    "page": 10
                },
                {
                    "level": "H1",
                    "text": "10. Applications of Biomarkers in Clinical Samples",
                    "page": 11
                },
                {
                    "level": "H2",
                    "text": "10.1. Sputum",
                    "page": 11
                },
                {
                    "level": "H2",
                    "text": "10.2. Bronchoalveolar Lavage (BAL)",
                    "page": 12
                },
                {
                    "level": "H2",
                    "text": "10.3. Peripheral Blood",
                    "page": 12
                },
                {
                    "level": "H2",
                    "text": "10.4. Urine",
                    "page": 13
                },
                {
                    "level": "H2",
                    "text": "10.5. Metabolomics",
                    "page": 14
                },
                {
                    "level": "H1",
                    "text": "11. Conclusions and Future Venues",
                    "page": 14
                },
                {
                    "level": "H1",
                    "text": "References",
                    "page": 15
                }
            ]
        }